Omega Healthcare Investors (OHI) Set to Announce Quarterly Earnings on Wednesday

Omega Healthcare Investors (NYSE:OHI - Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.69 per share for the quarter. Omega Healthcare Investors has set its FY24 guidance at $2.78-$2.84 EPS and its FY 2024 guidance at 2.780-2.840 EPS.Parties that wish to register for the company's conference call can do so using this link.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. During the same period in the previous year, the business posted $0.74 earnings per share. The firm's revenue for the quarter was up 17.5% on a year-over-year basis. On average, analysts expect Omega Healthcare Investors to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Omega Healthcare Investors Price Performance

OHI traded up $0.38 during trading on Wednesday, hitting $41.62. The company's stock had a trading volume of 1,136,610 shares, compared to its average volume of 1,648,054. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors has a twelve month low of $27.53 and a twelve month high of $41.76. The business's fifty day simple moving average is $39.86 and its 200 day simple moving average is $35.42. The firm has a market capitalization of $10.28 billion, a price-to-earnings ratio of 37.42, a P/E/G ratio of 1.34 and a beta of 1.00.

Wall Street Analysts Forecast Growth

OHI has been the topic of a number of research analyst reports. Mizuho lowered Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and lifted their price target for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They issued a "buy" rating and a $45.00 price target on the stock. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. BMO Capital Markets lifted their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a "market perform" rating in a research note on Monday, October 7th. Finally, Scotiabank lifted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research note on Monday, August 26th. Eight analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $37.80.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the business's stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company's stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.